Skip to main content
SpringerLink
Log in
Book cover

Hughes Syndrome pp 181–195Cite as

Obstetric Antiphospholipid Syndrome

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324–326.

    PubMed  CAS  Google Scholar 

  2. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classi.cation criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309–1311.

    Article  PubMed  CAS  Google Scholar 

  3. Levine JS, Rauch J, Branch DW. Anti-phospholipid syndrome. N Engl J Med 2002;346:752–763.

    Article  PubMed  CAS  Google Scholar 

  4. De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829–834.

    PubMed  Google Scholar 

  5. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985;313:1322–1326.

    Article  PubMed  CAS  Google Scholar 

  6. Lubbe WF, Butler WS, Palmer SJ, et al. Lupus anticoagulant in pregnancy. Br J Obstet 1984;91:357–363.

    CAS  Google Scholar 

  7. Nayar R, Lage JM. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature. Hum Pathol 1996;27:201–206.

    Article  PubMed  CAS  Google Scholar 

  8. Out HJ, Bruinse HW, Christiaens GCML, et al. Prevalence of aPL in patients with fetal loss. Ann Rheum Dis 1991;50:553–557.

    PubMed  CAS  Google Scholar 

  9. Khong TY, DeWolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small for gestational age infants. Br J Obstet Gynecol 1986;93:1049–1059.

    CAS  Google Scholar 

  10. Salafia CS, Parke AL. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum Dis Clin North Am 1997;23:85–97.

    Article  PubMed  CAS  Google Scholar 

  11. Peaceman AM, Rehnberg KA. The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1993;169:1403–1406.

    PubMed  CAS  Google Scholar 

  12. Branch DW, Rodgers GM. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am J Obstet Gynecol 1993;168:206–210.

    PubMed  CAS  Google Scholar 

  13. Dobado-Berrios PM, Lopez-Pedrera C, Velasco F, Aguirre MA, Torres A, Cuadrado MJ. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost 1999;82:1578–1582.

    PubMed  CAS  Google Scholar 

  14. Rand JH, Wu XX, Guller S, Gil J, Guha A, Scher J, Lockwood CJ. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566–1572.

    PubMed  CAS  Google Scholar 

  15. Rand JH, Wu XX, Guller S, Scher J, Andree HA, Lockwood CJ. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997;177:918–923.

    Article  PubMed  CAS  Google Scholar 

  16. Vogt E, Ng AK, Rote NS. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 1997;177:964–972.

    Article  PubMed  CAS  Google Scholar 

  17. Rand JH, Wu XX, Quinn AS, et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 2003;163:1193–1200.

    PubMed  CAS  Google Scholar 

  18. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997;56:50–58.

    Article  PubMed  CAS  Google Scholar 

  19. di Simone N, Meroni PL, Del Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000;43:140–150.

    Article  PubMed  Google Scholar 

  20. Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998;352:1037–1038.

    Article  PubMed  CAS  Google Scholar 

  21. Horkko S, Miller E, Dudl E, et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996;98:815–825.

    Article  PubMed  CAS  Google Scholar 

  22. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004;190:1177–1178.

    Article  PubMed  Google Scholar 

  23. Bonet B, Hauge-Gillenwater H, Zhu XD, Knopp RH. LDL oxidation and human placental trophoblast and macrophage activity. Proc Soc Exp Biol Med 1998;217:203–211.

    PubMed  CAS  Google Scholar 

  24. Pavan L, Tsatsaris V, Hermouet A, Theroud P, Evain-Brion D, Fournier T. Oxidized low-density lipoproteins inhibit trophoblastic cell invasion. J Clin Endocrinol Metab 2004;89:1969–1972.

    Article  PubMed  CAS  Google Scholar 

  25. Holers VM, Giradi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211–220.

    Article  PubMed  CAS  Google Scholar 

  26. Giradi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003;112:1644–1654.

    Article  CAS  Google Scholar 

  27. Hustin J, Schaaps JP. Echographic and anatomic studies of the naternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol 1987;157:162–168.

    PubMed  CAS  Google Scholar 

  28. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal pregnancies. Am J Pathol 2003;162:115–125.

    PubMed  Google Scholar 

  29. Burton GJ, Watson Al, Hempstock J, Skepper JN, Jauniaux E. Uterine glands provide histiotrophic nutrition for the uman fetus during the first trimester of pregnancy. J Clin Endocrinol Metab 2002;87:2954–2959.

    Article  PubMed  CAS  Google Scholar 

  30. Jauniaux E, Watson AL, Hempstock J, Bao Y-P, Skepper JN, Burton GJ. Onset of maternal arterial bloodflow and placental oxidative stress: a possible factor in human early pregnancy failure. Am J Pathol 2000;157:2111–2122.

    PubMed  CAS  Google Scholar 

  31. Boklage CE. Survival probability of human conceptions from fertilization to term. Int J Fertil 1990;35:75–93.

    PubMed  CAS  Google Scholar 

  32. Wilcox AJ, Weinberg CR, O’Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189–194.

    Article  PubMed  CAS  Google Scholar 

  33. Goldstein SR. Embryonic death in early pregnancy: a new look at the first trimester. Obstet Gynecol 1994;84:294–297.

    PubMed  CAS  Google Scholar 

  34. Miller JF, Williamson E, Glue J, Gordon YB, Grudzinskas JG, Sykes A. Fetal loss after implantation: a prospective study. Lancet 1980;ii:554–556.

    Article  Google Scholar 

  35. Edmonds DK, Lindsay KS, Miller JF, Williams E, Wood PJ. Early embryonic mortality in women. Fertil Steril 1982;38:447–453.

    PubMed  CAS  Google Scholar 

  36. Whitaker PG, Taylor A, Lind T. Unsuspected pregnancy loss in healthy women. Lancet 1983;i:1126–1127.

    Article  Google Scholar 

  37. Regan L. A prospective study of spontaneous abortion. In: Beard RW, Sharp F, eds. Early pregnancy loss. London: Springer-Verlag; 1988:23–37.

    Google Scholar 

  38. Warburton D, Fraser FC. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964;16:1–25.

    PubMed  CAS  Google Scholar 

  39. Fitzsimmons J, Jackson D, Wapner R, Jackson L. Subsequent reproductive outcome in couples with repeated pregnancy loss. Am J Med Genet 1983;16:583–587.

    Article  PubMed  CAS  Google Scholar 

  40. Stirrat GM. Recurrent miscarriage I: Identification and epidemiology. Lancet 1990;336:673–675.

    Article  PubMed  CAS  Google Scholar 

  41. Oyen N, Skjaerven R, Irgens LM. Population-based recurrence risk of sudden infant death syndrome compared with other infant and fetal deaths. Am J Epidemiol 1996;144:300.

    PubMed  CAS  Google Scholar 

  42. Samueloff A, Xenakis E, Berkus MD, Huff RW, Langer O. Recurrent stillbirth: significance and characteristics. J Reprod Med 1993;38:883–886.

    PubMed  CAS  Google Scholar 

  43. Stern JJ, Dorfmann AD, Gutierrez-Najar AJ, Cerrillo M, Coulam CB. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996;65:250–253.

    PubMed  CAS  Google Scholar 

  44. Sullivan A, et al. Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol 2004;104:784–788.

    PubMed  Google Scholar 

  45. Fox H. Histological classification of tissue from spontaneous abortions: a valueless exercise? Histopathology 1993;.22:599–600.

    PubMed  CAS  Google Scholar 

  46. Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med 1991;325:1063–1066.

    Article  PubMed  CAS  Google Scholar 

  47. Petri M, Golbus M, Anderson R, Whiting-O’Keefe Q, Corash L, Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987;30:601–606.

    PubMed  CAS  Google Scholar 

  48. Out HJ, Bruinse HW, Christiaens GCML, et al. Prevalence of aPL in patients with fetal loss. Ann Rheum Dis 1991;50:553–557.

    Article  PubMed  CAS  Google Scholar 

  49. Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S. APL and recurrent abortion. Obstet Gynecol 1991;77:854–858.

    PubMed  CAS  Google Scholar 

  50. Parke AL, Wilson D, Maier D. The prevalence of aPL in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991;34:1231–1235.

    PubMed  CAS  Google Scholar 

  51. Plouffe L Jr, White EW, Tho SP, et al. Etiologic factors of recurrent abortion and subsequent reproductive performance of couples: have we made any progress in the past 10 years? Am J Obstet Gynecol 1992;167:313–320.

    PubMed  Google Scholar 

  52. MacLean MA, Cumming GP, McCall F, Walker ID, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 1994;101:103–106.

    PubMed  CAS  Google Scholar 

  53. Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other aPL. Fertil Steril 1996;66:540–546.

    PubMed  CAS  Google Scholar 

  54. Branch DW, Silver RM, Pierangelli SS, van Leeuwen I, Harris EN. APL other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 1997;89:549–555.

    Article  PubMed  CAS  Google Scholar 

  55. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489–493.

    Article  PubMed  CAS  Google Scholar 

  56. Silver RM, Porter TF, van Leeuwen I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: clinical consequences of “low titers.” Obstet Gynecol 1996;87:494–500.

    Article  PubMed  CAS  Google Scholar 

  57. Aoki K, Hayashi Y, Hirao Y, Yagami Y. aPL as a predictive variable in patients with recurrent pregnancy loss. Am J Reprod Immunol 1993a;29:82–87.

    PubMed  CAS  Google Scholar 

  58. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003;101:1333–1344.

    Article  PubMed  Google Scholar 

  59. Derksen RH, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004;50:1028–1039.

    Article  PubMed  CAS  Google Scholar 

  60. Tulppala M, Marttunen M, Soderstrom-Anttila V, et al. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 1997;12:1567–1572.

    Article  PubMed  CAS  Google Scholar 

  61. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584–1589.

    PubMed  CAS  Google Scholar 

  62. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318–1323.

    PubMed  CAS  Google Scholar 

  63. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411–1417.

    PubMed  CAS  Google Scholar 

  64. Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996;35:402–407.

    PubMed  CAS  Google Scholar 

  65. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997;337:148–153.

    Article  PubMed  CAS  Google Scholar 

  66. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:253–257.

    PubMed  CAS  Google Scholar 

  67. Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000;183:1008–1012.

    Article  PubMed  CAS  Google Scholar 

  68. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002;100:408–413.

    Article  PubMed  CAS  Google Scholar 

  69. Balasch J, Carmona F, Lopez-Soto A, et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1993;8:2234–2239.

    PubMed  CAS  Google Scholar 

  70. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999;106:102–107.

    PubMed  CAS  Google Scholar 

  71. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995;10:3301–3304.

    PubMed  CAS  Google Scholar 

  72. Triolo G, Ferrane A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 2003;48:728–731.

    Article  PubMed  CAS  Google Scholar 

  73. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439–443.

    PubMed  CAS  Google Scholar 

  74. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614–620.

    PubMed  CAS  Google Scholar 

  75. Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996;14:131–136.

    PubMed  CAS  Google Scholar 

  76. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalunian KC. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990;75:630–634.

    PubMed  CAS  Google Scholar 

  77. Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000;182:122–127.

    Article  PubMed  CAS  Google Scholar 

  78. Pauzner R, Dulitzki M, Langevitz P, Livneh A, Kenett R, Many A. Low molecular weight heparin and warfarin the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001;86:1379–1384.

    PubMed  CAS  Google Scholar 

  79. Caruso A, de Carolis S, Ferrazzani S, Valesini G, Caforio L, Mancuso S. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993;82:970–977.

    PubMed  CAS  Google Scholar 

  80. Huong DLT, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette J-C. A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 2001;28:2025–2030.

    PubMed  CAS  Google Scholar 

  81. American College of Obstetricians and Gynecologists. Thromboembolism in pregnancy. ACOG Prac Bull 2000;19.

    Google Scholar 

  82. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119(suppl 1):122S–131S.

    Article  PubMed  CAS  Google Scholar 

  83. Fausett MB, Vogtlander M, Lee RM, et al. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 2001;185:148–152.

    Article  PubMed  CAS  Google Scholar 

  84. Druzin ML, Lockshin M, Edersheim TG, et al. Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. Am J Obstet Gynecol 1987;157:1503–1510.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obstetrics and Gynecology Diagnostic Center, University Hospital and Clinics, University of Utah Health Services Center, Salt Lake City, UT, USA

    T. Flint Porter MD & Robert M. Silver MD

  2. Department Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, University of Utah Health Services Center, Salt Lake City, UT, USA

    D. Ware Branch MD

Authors
  1. T. Flint Porter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert M. Silver MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Ware Branch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Porter, T.F., Silver, R.M., Branch, D.W. (2006). Obstetric Antiphospholipid Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_17

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_17

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation